Gemmer Asset Management LLC Ligand Pharmaceuticals Inc Transaction History

Gemmer Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$74.52 - $117.06 $2,086 - $3,277	-28 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$94.99 - $151.56 $474 - $757	5 Added 21.74%	28 $3,000
Q1 2020 May 01, 2020	SELL	$63.37 - $107.88 $126 - $215	-2 Reduced 8.0%	23 $1,000
Q2 2019 Jul 18, 2019	SELL	$107.38 - $129.34 $3,006 - $3,621	-28 Reduced 52.83%	25 $3,000
Q3 2017 Oct 12, 2017	BUY	$120.91 - $137.94 $6,408 - $7,310	53	53 $7,000

238

16.5M

77.9K

25K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.68B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.